Paratyphoid fever primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Paratyphoid fever}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Typhoid vaccine is recommended for travelers to areas where there is an increased risk of exposure to S.Typhi. | |||
===Indications for Use=== | |||
The typhoid vaccines do not protect against S. Paratyphi infection. Both typhoid vaccines protect 50%–80% of recipients; travelers should be reminded that typhoid immunization is not 100% effective, and typhoid fever could still occur. Two typhoid vaccines are available in the United States: | |||
*Oral live, [[attenuated]] [[vaccine]]. | |||
*Vi capsular polysaccharide vaccine for [[intramuscular]] use. | |||
==References== | ==References== | ||
Revision as of 16:33, 3 February 2012
|
Paratyphoid fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Paratyphoid fever primary prevention On the Web |
|
American Roentgen Ray Society Images of Paratyphoid fever primary prevention |
|
Risk calculators and risk factors for Paratyphoid fever primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Typhoid vaccine is recommended for travelers to areas where there is an increased risk of exposure to S.Typhi.
Indications for Use
The typhoid vaccines do not protect against S. Paratyphi infection. Both typhoid vaccines protect 50%–80% of recipients; travelers should be reminded that typhoid immunization is not 100% effective, and typhoid fever could still occur. Two typhoid vaccines are available in the United States:
- Oral live, attenuated vaccine.
- Vi capsular polysaccharide vaccine for intramuscular use.